UDK: 616.314.18-002.4:616-008.9
I. V. Starikova, N. N. Trigolos, I. V. Firsova, Yu. A. Makedonova, N. V. Piterskaya, E. B. Marymova
Волгоградский государственный медицинский университет, кафедра терапевтической стоматологии
The relationship between pathological changes in the periodontium and systemic disorders in metabolic syndrome (MS) has not yet been fully studied. In the present study 20 patients with chronic generalized periodontitis (CGP) of moderate severity accompanied by metabolic syndrome (35—55 years) were thoroughly examined and treated. After treatment, the clinical signs of inflammation reduced. Along with clinical improvement, we observed positive changes in clinical and immunological parameters. We conclude that treatment plan of patients with chronic generalized moderate periodontitis accompanied by metabolic syndrome should include immunomodulatory therapy.
periodontal disease, metabolic syndrome, immunoglobulins, therapy.
Питерская Наталия Валерьевна — к. м. н., ассистент кафедры терапевтической стоматологии, Волгоградский государственный медицинский университет, e-mail: Piterskij.k@yandex.ru